Indivior · 2 months ago
Director, IT – Commercial Applications, Business Intelligence
Richmond, VA
Full-time
Onsite
Director/Executive
10+ years expIndivior is a global pharmaceutical company focused on developing medicines for opioid use disorder. They are seeking a visionary Director of IT to lead the strategy and optimization of Commercial Applications, Business Intelligence, and Artificial Intelligence, driving digital transformation and enhancing decision-making across various departments.
Addiction TreatmentBiotechnologyCommunitiesHealth CareMedicalPharmaceuticalSocial
Responsibilities
Define and execute the IT roadmap for Commercial Applications, BI, and AI aligned with corporate and commercial business strategies
Partner with Commercial, Data Science, and Analytics leaders to identify opportunities for innovation and operational efficiency
Lead cross-functional teams to deliver scalable, secure, and compliant technology solutions
Oversee the implementation and lifecycle management of Veeva CRM and other commercial platforms
Ensure seamless integration of commercial systems with ERP, data lakes, and third-party data providers
Drive enhancements to support field force effectiveness, omnichannel engagement, and HCP/patient insights
Lead the BI strategy, including data architecture, visualization tools (e.g., Tableau, Power BI), and self-service analytics
Establish KPIs and dashboards to monitor commercial performance, market trends, and customer engagement
Ensure data governance, quality, and compliance with industry regulations (e.g., HIPAA, GDPR)
Champion the adoption of AI/ML models to optimize targeting, forecasting, segmentation, and personalization
Collaborate with data science teams to operationalize predictive and prescriptive analytics
Evaluate emerging technologies and vendors to accelerate AI maturity across the organization
Qualification
Required
Bachelor's degree in Computer Science, Information Systems, or related field; Master's or MBA preferred
10+ years of progressive IT leadership experience, with at least 5 years in the pharmaceutical or life sciences industry
Proven track record in managing commercial applications, BI platforms, and AI initiatives
Deep understanding of commercial pharma operations, data ecosystems, and regulatory requirements
Strong vendor management, project delivery, and stakeholder engagement skills
Experience with cloud platforms (AWS, Azure), data lakes, and modern data stack tools
Preferred
Familiarity with Veeva CRM, IQVIA data, and AI/ML frameworks
Change management and agile delivery experience
Excellent communication and leadership skills with the ability to influence at all levels
Benefits
3 weeks’ vacation plus floating holidays and sick leave, plus company closure from December 24th- January 1st
401(k) and Profit Sharing Plan- Company match of 75% on your first 6% of contributions and profit sharing contribution equal to 4% of your eligible pay
U.S. Employee Stock Purchase Plan- 15% Discount
Comprehensive Medical, Dental, Vision, Life and Disability coverage
Health, Dependent Care and Limited Purpose Flex Spending and HSA options
Adoption assistance
Tuition reimbursement
Concierge/personal assistance services
Voluntary benefits including Legal, Pet Insurance and Critical Illness coverage
Gym, fitness facility and cell phone discounts
Company
Indivior
Indivior is a specialty pharmaceuticals business.
1001-5000 employees
H1B Sponsorship
Indivior has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (5)
2023 (5)
2022 (6)
2021 (4)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$400MKey Investors
Piper SandlerOaktree Capital Management
2024-11-05Post Ipo Debt· $400M
2024-07-12Post Ipo Equity
2014-12-23IPO
Leadership Team
Mark Crossley
Chief Executive Officer
Recent News
2026-01-13
2026-01-09
Company data provided by crunchbase